Methods of use of epsilon inhibitor compounds for the attenuation of pain

Details for Australian Patent Application No. 2008206028 (hide)

Owner KAI Pharmaceuticals, Inc.

Inventors Maclean, Derek; Yin, Kevin

Agent Griffith Hack

Pub. Number AU-A-2008206028

PCT Pub. Number WO2008/089494

Priority 60/881,396 19.01.07 US; 60/903,684 26.02.07 US; 60/917,876 14.05.07 US; 60/977,332 03.10.07 US

Filing date 22 January 2008

Wipo publication date 24 July 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/03 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/089494 Priority application(s): WO2008/089494

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008206039-Inhibitors of D-amino acid oxidase

2008206002-Processes for production of liquid fuel